Patents by Inventor Yuichi Makinose

Yuichi Makinose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AORTIC ANEURYSM
    Publication number: 20240041857
    Abstract: The present invention addresses the problem of providing a therapeutic agent for abdominal aortic aneurysms, with which pharmacotherapy is possible. The present invention provides a therapeutic agent for an aortic aneurysm comprising, as an active component, (?)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these.
    Type: Application
    Filed: October 18, 2023
    Publication date: February 8, 2024
    Inventors: Naoki Unno, Hiroki Tanaka, Tatsuro Yata, Keisuke Inoue, Yuichi Makinose, Noboru Kaneta
  • PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AORTIC ANEURYSM
    Publication number: 20220023286
    Abstract: The present invention addresses the problem of providing a therapeutic agent for abdominal aortic aneurysms, with which pharmacotherapy is possible. The present invention provides a therapeutic agent for an aortic aneurysm comprising, as an active component, (?)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Inventors: Naoki Unno, Hiroki Tanaka, Tatsuro Yata, Keisuke Inoue, Yuichi Makinose, Noboru Kaneta
  • Pharmaceutical composition for treatment of aortic aneurysm
    Patent number: 11166948
    Abstract: The present invention addresses the problem of providing a therapeutic agent for abdominal aortic aneurysms, with which pharmacotherapy is possible. The present invention provides a therapeutic agent for an aortic aneurysm comprising, as an active component, (?)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: November 9, 2021
    Assignees: National University Corporation Hamamatsu University School of Medicine, Kowa Company, Ltd.
    Inventors: Naoki Unno, Hiroki Tanaka, Tatsuro Yata, Keisuke Inoue, Yuichi Makinose, Noboru Kaneta
  • PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AORTIC ANEURYSM
    Publication number: 20200215050
    Abstract: The present invention addresses the problem of providing a therapeutic agent for abdominal aortic aneurysms, with which pharmacotherapy is possible. The present invention provides a therapeutic agent for an aortic aneurysm comprising, as an active component, (?)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these.
    Type: Application
    Filed: September 13, 2018
    Publication date: July 9, 2020
    Inventors: Naoki Unno, Hiroki Tanaka, Tatsuro Yata, Keisuke Inoue, Yuichi Makinose, Noboru Kaneta